$170.00
PT-141 (Bremelanotide) is a synthetic peptide derived from melanocortin, primarily known for its
role in enhancing sexual arousal and addressing sexual dysfunction. It works by activating
melanocortin receptors in the brain, which influence sexual desire and arousal. Unlike other
treatments for erectile dysfunction or low libido, PT-141 acts on the central nervous system
rather than the vascular system. It is FDA-approved for the treatment of hypoactive sexual
desire disorder (HSDD) in premenopausal women and is also being studied for its potential in
treating similar conditions in men.
nexgenresearch.com. All Rights Reserved.
All products on this site are for Research, Development use only. Products are Not for Human consumption of any kind.
The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease.
Peptide Sciences is a chemical supplier. Peptide Sciences is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic act. Peptide Sciences is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic act.
Reviews
There are no reviews yet.